1. Home
  2. ELVN vs POST Comparison

ELVN vs POST Comparison

Compare ELVN & POST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

N/A

Current Price

$46.48

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Logo Post Holdings Inc.

POST

Post Holdings Inc.

N/A

Current Price

$79.44

Market Cap

5.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
ELVN
POST
Founded
2016
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
5.0B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ELVN
POST
Price
$46.48
$79.44
Analyst Decision
Strong Buy
Buy
Analyst Count
14
7
Target Price
$74.33
★ $96.67
AVG Volume (30 Days)
★ 1.2M
656.3K
Earning Date
11-05-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
3.17
★ 10.53
EPS
N/A
★ 6.09
Revenue
N/A
★ $8,120,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.87
P/E Ratio
★ N/A
$17.27
Revenue Growth
★ N/A
N/A
52 Week Low
$14.79
$71.45
52 Week High
$62.32
$116.35

Technical Indicators

Market Signals
Indicator
ELVN
POST
Relative Strength Index (RSI) 49.64 52.19
Support Level $44.18 $76.27
Resistance Level $46.96 $86.87
Average True Range (ATR) 2.47 2.72
MACD -0.17 -0.39
Stochastic Oscillator 25.69 40.43

Price Performance

Historical Comparison
ELVN
POST

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About POST Post Holdings Inc.

Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.

Share on Social Networks: